The NF2 gene encodes merlin (also known as schwannomin), a tumor suppressor that integrates membrane signaling with the cortical cytoskeleton to enforce contact inhibition and maintain tissue homeostasis. Located on chromosome 22q12, the NF2 gene has a structure related to the ERM (ezrin-radixin-moesin) family of proteins and contains an N-terminal FERM domain that interacts with membrane proteins, adhesion complexes, and actin-associated scaffolds. Merlin acts as a context-dependent regulator of multiple growth and mechanotransduction pathways, including the Hippo pathway (by influencing LATS/YAP/TAZ activity), the PI3K-AKT-mTOR and Ras-Raf-MEK-ERK signaling pathways, and receptor trafficking and ubiquitin ligase complexes (e.g., CRL4-DCAF1). Through these nodes, merlin inhibits cell proliferation, regulates cell morphology and migration, and maintains apical-basal polarity. Loss-of-function germline mutations in the NF2 gene cause neurofibromatosis type 2, characterized by bilateral vestibular schwannomas and commonly associated meningiomas and ependymomas; somatic inactivation also occurs in sporadic tumors, including mesotheliomas and some meningiomas.
Human NF2 adenovirus particles are replication-deficient adenoviral vectors engineered to deliver and transiently express human NF2 cDNA, enabling controlled restoration or modulation of merlin activity in cells and preclinical models. They are widely used in functional rescue experiments in NF2-deficient or null cell lines, allowing researchers to directly attribute phenotypes to merlin deficiency and dissect downstream pathway dependencies of NF2. By reintroducing merlin, researchers can assess changes in contact inhibition, cytoskeletal organization, Hippo/YAP target gene expression, and sensitivity to pathway inhibitors, thus elucidating which signaling axes are dominant in specific cellular contexts. In oncology research, these particles are useful for evaluating the restoration of tumor suppressor function in schwannoma and meningioma models and can be extended to other malignancies with NF2 gene alterations, such as mesothelioma, where NF2 restoration can be combined with pharmacological blockade of mTOR or FAK to explore synthetic lethality.
β-Adrenergic receptor (β-AR) stimulation induces cardiomyocyte apoptosis in vitro and in vivo. Neurofibromin 2 (NF2) is a member of the ezrin/radixin/moesin (ERM) family of proteins. Post-translational modifications, such as phosphorylation and sumoylation, affect NF2 activity, subcellular localization, and function. Here, treatment of adult rat ventricular myocytes (ARVMs) with a β-AR agonist (isoproterenol) for 15 minutes increased NF2 phosphorylation (serine-518) and sumoylation. Specific inhibition of β1-AR and protein kinase A (PKA) reduced the β-AR-stimulated increase in NF2 post-translational modifications, whereas inhibition of β2-AR had no effect. Adenoviral stimulation of β-AR and expression of wild-type (WT)-NF2 increased phosphorylation of mammalian sterile-like kinase 1/2 (MST1/2) and YAP activating protein (YAP), downstream targets of NF2. Knockdown of NF2 in H9C2 cardiomyocytes using siRNA reduced the β-AR-stimulated increase in NF2 and YAP phosphorylation. siRNA-mediated knockdown of NF2 reduced the β-AR-stimulated increase in apoptosis, whereas expression of WT-NF2 induced apoptosis in ARVM cells. Expression of WT-NF2 stimulated the mitochondrial death pathway, as indicated by activation of c-Jun N-terminal kinase (JNK) and increased cytosolic cytochrome c levels and Bax expression.
In ARVMs, β-AR-stimulated apoptosis occurs through the engagement of the JNK and mitochondrial death pathways. To investigate the involvement of the mitochondrial death pathway, researchers measured JNK activation, Bax and Bcl2 expression, and cytoplasmic cytochrome c levels in ARVMs infected with adenovirus expressing WT-NF2 for 48 hours. Western blot analysis of cell lysates using a phospho-specific JNK antibody revealed a significant increase (approximately 1.6-fold) in phosphorylation of JNK (46 and 54 KDa) compared to cells expressing GFP (Figure 1A). NF2 expression also increased the protein level of the pro-apoptotic protein Bax by approximately 1.5-fold (Figure 1B). The protein level of Bcl2 remained unchanged. The Bcl2/Bax ratio was significantly lower in cells expressing NF2 (Figure 1C). The level of cytoplasmic cytochrome c was significantly higher in cells expressing WT-NF2 compared with cells expressing GFP (approximately 1.6-fold; Figure 1D).
Figure 1. Adenoviral-mediated expression of NF2 activates mitochondrial death pathway in ARVMs. (Dalal S, et al., 2018)
Customer Reviews
Remarkable Efficiency
The Human NF2 adenoviral particles from Creative Biogene are truly outstanding. They exhibit remarkable efficiency in transgene expression, making them an integral tool for my research on neurofibromatosis type 2.
Write a Review